Aohua Pharmaceutical: Net profit in the first half of the year is expected to decrease by 82.52%85.61% year-on-year.

Kuohua Pharmaceuticals disclosed its performance forecast on the evening of July 11th, expecting a net profit attributable to shareholders of the listed company of 70-85 million yuan in the first half of 2025, a year-on-year decrease of 82.52% to 85.61%. During the reporting period, the company's inventory of raw materials costs remained high, coupled with a decrease in production scale leading to an increase in fixed costs, resulting in an increase in operating costs and significantly impacting the gross profit margin of product sales.